SARCOMATOID CARCINOMA OF THE LUNG: A CLINICOPATHOLOGICAL STUDY INCLUDING EGFR AND KRAS MUTATION AND ALK PROTEIN EXPRESSION ANALYSIS

被引：0
|
作者：
Jia, X-L [1 ]
Chen, G. [1 ]
机构：
[1] Tongji Univ, Dept Pathol, Sch Med, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China
来源：
RESPIROLOGY | 2011年 / 16卷
关键词：
Sarcomatoid carcinoma; EGFR mutation; KRAS mutation; ALK protein expression;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [1] Pulmonary Pleomorphic Carcinoma A Clinicopathological Study Including EGFR Mutation Analysis
    Kaira, Kyoichi
    Horie, Yoshiki
    Ayabe, Eriko
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Tsuya, Asuka
    Nakamura, Yukiko
    Naito, Tateaki
    Endo, Masahiro
    Kondo, Haruhiko
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (04) : 460 - 465
  • [2] Poor prognosis of pulmonary sarcomatoid carcinoma with KRAS mutation and ALK fusion
    Chen, Fangmin
    Gu, Qihua
    Hu, Chengping
    Cai, Xiaoling
    Lei, Shuhua
    ONCOTARGETS AND THERAPY, 2019, 12 : 3321 - 3325
  • [3] MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status
    Kim, Hyojin
    Yang, Jeong Mi
    Jin, Yan
    Jheon, Sanghoon
    Kim, Kwhanmien
    Lee, Choon Taek
    Chung, Jin-Haeng
    Paik, Jin Ho
    ONCOTARGET, 2017, 8 (05) : 8484 - 8498
  • [4] Lung Adenocarcinoma in Young Adults: EGFR/KRAS/ALK Mutation Status and Clinicopathological Features in 64 Patients under Age 40
    Dogan, S.
    Jhanwar, S. C.
    Ladanyi, M.
    Zakowski, M. F.
    MODERN PATHOLOGY, 2011, 24 : 407A - 408A
  • [5] 58 Cases of EGFR/ALK Gene Status Analysis in Pulmonary Sarcomatoid Carcinoma
    Huang, Y.
    Xu, C.
    Wang, W.
    Zhuang, W.
    Song, Z.
    Chen, Y.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2262 - S2262
  • [6] Lung Adenocarcinoma in Young Adults: EGFR/KRAS/ALK Mutation Status and Clinicopathological Features in 64 Patients under Age 40.
    Dogan, S.
    Jhanwar, S. C.
    Ladanyi, M.
    Zakowski, M. F.
    LABORATORY INVESTIGATION, 2011, 91 : 407A - 408A
  • [7] Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers
    Chapman, Aaron M.
    Sun, Kathie Y.
    Ruestow, Peter
    Cowan, Dallas M.
    Madl, Amy K.
    LUNG CANCER, 2016, 102 : 122 - 134
  • [8] PD-L1 Expression in Primary Lung Adenocarcinoma and its Relation with EGFR / KRAS Mutation and Clinicopathological Features
    Li, L.
    Guo, C.
    Guo, L.
    Dai, H.
    Ying, J.
    Gao, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S761 - S761
  • [9] Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma
    Cai, Guoping
    Wong, Rebecca
    Chhieng, David
    Levy, Gillian H.
    Gettinger, Scott N.
    Herbst, Roy S.
    Puchalski, Jonathan T.
    Homer, Robert J.
    Hui, Pei
    CANCER CYTOPATHOLOGY, 2013, 121 (09) : 500 - 507
  • [10] Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia
    Brcic, Luka
    Jakopovic, Marko
    Misic, Marija
    Seiwerth, Fran
    Kern, Izidor
    Smojver-Jezek, Silvana
    Quehenberger, Franz
    Samarzija, Miroslav
    Seiwerth, Sven
    DIAGNOSTIC PATHOLOGY, 2016, 11 : 1
12345